| Date | Time | Source | Headline | Symbol | Company |
| 09/21/2009 | 6:39PM | Dow Jones News | Boehringer Ingelheim To Acquire Wyeth's Animal Health Assets | NYSE:WYE | Wyeth |
| 09/21/2009 | 5:05PM | Business Wire | Pfizer and Wyeth to Divest Certain Animal Health Assets to Boehringer Ingelheim | NYSE:WYE | Wyeth |
| 09/18/2009 | 3:05PM | Dow Jones News | Vivus Keeps Lead As Obesity Drug Race Turns Into Homestretch | NYSE:WYE | Wyeth |
| 09/18/2009 | 10:12AM | Dow Jones News | UPDATE: Arena Reports Obesity Drug Success; Data Disappoint | NYSE:WYE | Wyeth |
| 09/18/2009 | 8:00AM | PR Newswire (US) | Wyeth and Ambrx Form Multi-target Alliance to Leverage Recent Ambrx Biologics Platform Advances | NYSE:WYE | Wyeth |
| 09/18/2009 | 12:31AM | Dow Jones News | Arena Reports Obesity Drug Success, But Data May Disappoint | NYSE:WYE | Wyeth |
| 09/17/2009 | 11:48AM | Dow Jones News | Drug Stocks Advance; Sequenom Jumps On Launch | NYSE:WYE | Wyeth |
| 09/16/2009 | 7:32PM | Dow Jones News | 2nd UPDATE: Pharma Gets What It Lobbied For In Senate Health Bill | NYSE:WYE | Wyeth |
| 09/16/2009 | 4:38PM | Dow Jones News | UPDATE: Pharma Gets What It Lobbied For In Senate Health Bill | NYSE:WYE | Wyeth |
| 09/15/2009 | 4:33PM | Edgar (US Regulatory) | Termination of Registration of a Class of Security under Section 12(b) (15-12B) | NYSE:WYE | Wyeth |
| 09/15/2009 | 8:00AM | PR Newswire (US) | Wyeth Presents Data from Five-Year Vertebral Fracture Prevention Study with Bazedoxifene | NYSE:WYE | Wyeth |
| 09/10/2009 | 6:25AM | Marketwired | AnalystChoice.com Brings You the Best Complimentary Research Report on HOG, KEY, PHM, TSM, JEF and WYE | NYSE:WYE | Wyeth |
| 09/09/2009 | 10:40AM | Dow Jones News | 2nd UPDATE: Vivus Reports Robust Data From Weight-Loss Drug | NYSE:WYE | Wyeth |
| 09/09/2009 | 9:59AM | Dow Jones News | UPDATE: Vivus Reports Robust Data From Weight-Loss Drug | NYSE:WYE | Wyeth |
| 09/02/2009 | 3:34PM | Dow Jones News | 2nd UPDATE: Pfizer In $2.3 Billion Drug-Marketing Case Settlement | NYSE:WYE | Wyeth |
| 09/02/2009 | 1:25PM | Dow Jones News | UPDATE: Pfizer In $2.3 Billion Drug-Marketing Case Settlement - DOJ | NYSE:WYE | Wyeth |
| 09/02/2009 | 11:13AM | Dow Jones News | Pfizer To Pay $2.3 Billion To Settle Case On Drug Marketing - DOJ | NYSE:WYE | Wyeth |
| 08/26/2009 | 6:12AM | Marketwired | TheFortuneFinancial.com Free Market Research on WYE, HPT, KFN, RGC, OPWV and TIBX | NYSE:WYE | Wyeth |
| 08/24/2009 | 9:27AM | Dow Jones News | Shire Inks Research Deal With Denmark's Santaris | NYSE:WYE | Wyeth |
| 08/17/2009 | 2:22PM | PR Newswire (US) | Wyeth Announces Full Redemption of Floating Rate Convertible Senior Debentures Due 2024 | NYSE:WYE | Wyeth |
| 08/14/2009 | 12:40PM | Dow Jones News | FDA, Roche Warn On Type Of Anemia With Kidney-Transplant Drug | NYSE:WYE | Wyeth |
| 08/12/2009 | 3:50PM | Dow Jones News | PHARMA MARKET:Onyx, Bayer Seek To Continue Nexavar Expansion | NYSE:WYE | Wyeth |
| 08/12/2009 | 6:58AM | Marketwired | WallStSense.com Fundamental & Technical Coverage of ADI, WYE, TWX, ARE, UNP and TM | NYSE:WYE | Wyeth |
| 08/11/2009 | 5:25PM | Dow Jones News | FDA Extends Prevnar 13 Review Until Year's End | NYSE:WYE | Wyeth |
| 08/11/2009 | 4:30PM | PR Newswire (US) | Wyeth Provides Regulatory Update on Prevnar 13* in the United States | NYSE:WYE | Wyeth |
| 08/11/2009 | 1:10PM | Dow Jones News | CORRECT: Crucell Posts 2Q Net Loss, Keeps FY09 Guidance | NYSE:WYE | Wyeth |
| 08/11/2009 | 7:59AM | Dow Jones News | 2nd UPDATE: Crucell Posts 2Q Net Loss, Keeps FY09 Guidance | NYSE:WYE | Wyeth |
| 08/11/2009 | 3:29AM | Dow Jones News | UPDATE: Crucell Posts 2Q Net Loss, Keeps FY09 Guidance | NYSE:WYE | Wyeth |
| 08/11/2009 | 2:34AM | Dow Jones News | Crucell Posts 2Q Net Loss, Keeps FY09 Guidance | NYSE:WYE | Wyeth |
| 08/07/2009 | 1:20PM | Dow Jones News | Pfizer To Explore Sale Or Licensing Of Fablyn Bone Drug | NYSE:WYE | Wyeth |